½ÃÀ庸°í¼­
»óǰÄÚµå
1193105

È£Èí¿ë ¸¶½ºÅ© ½ÃÀå : À¯Çüº°(ÀÏȸ¿ë, ÀçÀÌ¿ë °¡´É), ¿¬·ÉÃþº°(½Å»ý¾Æ¿Í ¼Ò¾Æ, ¼ºÀÎ, ³ëÀÎ), ÃÖÁ¾ »ç¿ëÀÚº°(º´¿ø, ¿ä¾ç¿ø°ú Ŭ¸®´Ð, ¿Ü»ó ¼¾ÅÍ, ÀçÅ𣺴) - ¼¼°è ±âȸ ºÐ¼® ¹× »ê¾÷ ¿¹Ãø(2021-2031³â)

Respiratory Masks Market By Type (Disposable, Reusable), By Age Group (Neonatal & Pediatric, Adult , Geriatric), By End User (Hospitals, Nursing Homes & Clinics, Trauma Centers, Homecare): Global Opportunity Analysis & Industry Forecast, 2021-2031

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Allied Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 299 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

È£Èí¿ë ¸¶½ºÅ©ÀÇ ¼¼°è ½ÃÀåÀº 2021³â¿¡ 5¾ï 2710¸¸ ´Þ·¯·Î 2022³âºÎÅÍ 2031³â¿¡ °ÉÃÄ CAGR 16.4%¸¦ ±â·ÏÇßÀ¸¸ç 2031³â¿¡´Â 23¾ï 9430¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

È£Èí¿ë ¸¶½ºÅ©´Â ºÐÁø, Áõ±â, °¡½º, ¹Ì¸³ÀÚ ¹°Áú µî ÀáÀçÀûÀ¸·Î À¯ÇØÇÑ ºÐÀ§±â¸¦ »ç¿ëÀÚ°¡ ÈíÀÔÇÏ´Â °ÍÀ» ¹æÁöÇϱâ À§ÇØ ¸¸µé¾îÁø ÀåºñÀÔ´Ï´Ù. ¸¶½ºÅ©´Â ÀÔ°ú ÄÚ¿¡ ÀåÂøÇϰí ÈíÀÔÇÑ °ø±â·ÎºÎÅÍ À§Çè ¹°Áú(¸ÕÁö, ¿¬±â, ¹ÚÅ׸®¾Æ µî)À» ¿©°úÇÏ¿© È£Èí±â ½Ã½ºÅÛÀ» º¸È£ÇÏ´Â ÀåÄ¡·Î Á¤Àǵ˴ϴÙ. ¹Ì¸³ÀÚ ¹°ÁúÀÇ ¸¶½ºÅ©´Â ÀÔÀÚ¸¸À» ¿©°ú ÇÒ ¼ö ÀÖÀ¸¸ç ±âü ³ª Áõ±â¿¡ È¿°ú°¡ ¾ø½À´Ï´Ù. ÀÌ·¯ÇÑ ¸¶½ºÅ©¿¡´Â ¿©°úµÇ´Â ÀÔÀÚÀÇ ¾çÀ» ³ªÅ¸³»´Â 95¿Í 99¿Í °°Àº ¼öÄ¡°¡ Ç¥½ÃµÉ ¼ö ÀÖ½À´Ï´Ù.

È£Èí¿ë ¸¶½ºÅ© ½ÃÀåÀº COVID-19ÀÇ À¯º´·ü »ó½Â°ú õ½Ä, ¸¸¼º Æó»ö¼º ÆóÁúȯ(COPD), õ½Ä, Æó¾Ï, Æó»ö¼º ¼ö¸é ¹«È£ÈíÁõÈıº(OSA) µî È£Èí±â ÁúȯÀÇ À¯º´ ºñÀ²ÀÇ »ó½Â¿¡ ÀÇÇØ ÃßÁøµÇ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ¼¼°èº¸°Ç±â±¸(WHO)¿¡ µû¸£¸é, 2022³â 9¿ù COVID-19ÀÇ È®Á¤ »ç·Ê´Â 6,472,914¸íÀÇ »ç¸ÁÀ» Æ÷ÇÔÇÑ 600,555,262¸íÀÌ´Ù. Äڷγª¹ÙÀÌ·¯½º °¨¿°(COVID-19)Àº SARS-CoV-2 ¹ÙÀÌ·¯½º¿¡ ÀÇÇÑ °¨¿°ÀÔ´Ï´Ù. ÀÌ ¹ÙÀÌ·¯½º¿¡ °¨¿°µÇ¸é ´ëºÎºÐÀÇ »ç¶÷µéÀº °æÁõ¿¡¼­ ÁߵÀÇ È£Èí±â ÁúȯÀ» °æÇèÇÕ´Ï´Ù. COVID-19´Â °ø±â¿¡ °¨¿°µÇ±â ¶§¹®¿¡ ¿¹¹æÀ» À§ÇÑ È£Èí±â ¸¶½ºÅ©ÀÇ ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. µû¶ó¼­ COVID-19 ÁúȯÀÇ À¯º´·ü Áõ°¡´Â È£Èí±â ¸¶½ºÅ© ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, ºÒ¸®ÇÑ ±âÈÄ Á¶°Ç°ú ´ë±â ¿À¿°Àº ¸¸¼º Æó»ö¼º Æó Áúȯ(COPD), õ½Ä, Æó¾Ï, Æó¼â¼º ¼ö¸é ¹«È£Èí ÁõÈıº(OSA)°ú °°Àº È£Èí±â ÁúȯÀÇ À¯º´·üÀ» ³ôÀÌ´Â ÁÖ¿ä ¿øÀÎÀÔ´Ï´Ù. , Â÷·Ê·Î, ±×°ÍÀº ½ÃÀåÀÇ ¼ºÀåÀ» °­È­Çϰí È£Èí ¸¶½ºÅ©ÀÇ ¼ö¿ä¸¦ µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î ¼¼°è¾Ï ¿¬±¸±â±Ý ÀÎÅͳ»¼Å³Î¿¡ µû¸£¸é 2020³â¿¡´Â ¼¼°è¿¡¼­ ¾à 2,206,771°ÇÀÇ Æó¾ÏÀÌ »õ·Ó°Ô Áø´ÜµÇ¾ú½À´Ï´Ù. ÀÌ Áß ³²¼º 1,435,943¸í, ¿©¼º 770,828¸íÀÌ ÀÌȯÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ È¯°æ¿¡¼­ ´ë±â ¿À¿°ÀÌ Áõ°¡Çϰí È£Èí ¸¶½ºÅ©ÀÇ È¿´É¿¡ ´ëÇÑ »ç¶÷µéÀÇ ÀǽÄÀÌ Áõ°¡ÇÏ¸é ½ÃÀå ¼ºÀåÀÌ ÃËÁø µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼Ò°³

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå °³¿ä

  • ½ÃÀåÀÇ Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä Á¶»ç °á°ú
    • ÁÖ¿ä ÅõÀÚ Æ÷ÄÏ
  • Porter's Five Forces ºÐ¼®
  • ÁÖ¿ä ±â¾÷ÀÇ Æ÷Áö¼Å´×
  • ½ÃÀå ¿ªÇÐ
    • ÃËÁø ¿äÀÎ
    • ¾ïÁ¦ ¿äÀÎ
    • ±âȸ
  • COVID-19 ¿µÇ⠺м®
  • ƯÇã »óȲ

Á¦4Àå È£Èí¿ë ¸¶½ºÅ© ½ÃÀå : À¯Çüº°

  • °³¿ä
    • ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø
  • ÀÏȸ¿ë ŸÀÔ
    • ÁÖ¿ä ½ÃÀå µ¿Çâ, ¼ºÀå ¿äÀÎ, ±âȸ
    • ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : Áö¿ªº°
    • ½ÃÀå ºÐ¼® : ±¹°¡º° ºÐ¼®
    • ÀÏȸ¿ë È£Èí¿ë ¸¶½ºÅ©ÀÇ ½ÃÀå : ½Ã¸®Á
      • N½Ã¸®Áî ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : Áö¿ªº°
      • P½Ã¸®Áî ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : Áö¿ªº°
      • R½Ã¸®Áî ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : Áö¿ªº°
  • Àç»ç¿ëÇü
    • ÁÖ¿ä ½ÃÀå µ¿Çâ, ¼ºÀå ¿äÀÎ, ±âȸ
    • ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : Áö¿ªº°
    • ½ÃÀå ºÐ¼® : ±¹°¡º°

Á¦5Àå È£Èí¿ë ¸¶½ºÅ© ½ÃÀå : ¿¬·ÉÃþº°

  • °³¿ä
    • ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø
  • ½Å»ý¾Æ?¼Ò¾Æ
    • ÁÖ¿ä ½ÃÀå µ¿Çâ, ¼ºÀå ¿äÀÎ, ±âȸ
    • ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : Áö¿ªº°
    • ½ÃÀå ºÐ¼® : ±¹°¡º°
  • ¼ºÀοë
    • ÁÖ¿ä ½ÃÀå µ¿Çâ, ¼ºÀå ¿äÀÎ, ±âȸ
    • ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : Áö¿ªº°
    • ½ÃÀå ºÐ¼® : ±¹°¡º°
  • ³ë³â
    • ÁÖ¿ä ½ÃÀå µ¿Çâ, ¼ºÀå ¿äÀÎ, ±âȸ
    • ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : Áö¿ªº°
    • ½ÃÀå ºÐ¼® : ±¹°¡º°

Á¦6Àå È£Èí¿ë ¸¶½ºÅ© ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • °³¿ä
    • ½ÃÀå ±Ô¸ð¡¤¿¹Ãø
  • º´¿ø, ¿ä¾ç¿ø, Ŭ¸®´Ð
    • ÁÖ¿ä ½ÃÀå µ¿Çâ, ¼ºÀå ¿äÀÎ, ±âȸ
    • ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : Áö¿ªº°
    • ½ÃÀå ºÐ¼® : ±¹°¡º°
  • ¿Ü»ó ¼¾ÅÍ
    • ÁÖ¿ä ½ÃÀå µ¿Çâ, ¼ºÀå ¿äÀÎ, ±âȸ
    • ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : Áö¿ªº°
    • ½ÃÀå ºÐ¼® : ±¹°¡º°
  • ÀçÅà ÀÇ·á
    • ÁÖ¿ä ½ÃÀå µ¿Çâ, ¼ºÀå ¿äÀÎ, ±âȸ
    • ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : Áö¿ªº°
    • ½ÃÀå ºÐ¼® : ±¹°¡º°

Á¦7Àå È£Èí¿ë ¸¶½ºÅ© ½ÃÀå : Áö¿ªº°

  • °³¿ä
    • ½ÃÀå ±Ô¸ð¡¤¿¹Ãø
  • ºÏ¹Ì
    • ÁÖ¿ä µ¿Çâ°ú ±âȸ
    • ºÏ¹ÌÀÇ ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : À¯Çüº°
      • ºÏ¹ÌÀÇ ÀÏȸ¿ë½Ä È£Èí¿ë ¸¶½ºÅ© ½ÃÀå : ½Ã¸®Á
    • ºÏ¹ÌÀÇ ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : ¿¬·ÉÃþº°
    • ºÏ¹Ì ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : ÃÖÁ¾ »ç¿ëÀÚº°
    • ºÏ¹Ì ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : ±¹°¡º°
      • ¹Ì±¹
      • ij³ª´Ù
      • ¸ß½ÃÄÚ
  • À¯·´
    • ÁÖ¿ä µ¿Çâ°ú ±âȸ
    • À¯·´ ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : À¯Çüº°
      • À¯·´ÀÇ ÀÏȸ¿ë È£Èí¿ë ¸¶½ºÅ© ½ÃÀå : ½Ã¸®Á
    • À¯·´ ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : ¿¬·ÉÃþº°
    • À¯·´ ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : ÃÖÁ¾ »ç¿ëÀÚº°
    • À¯·´ ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : ±¹°¡º°
      • µ¶ÀÏ
      • ÇÁ¶û½º
      • ¿µ±¹
      • ÀÌÅ»¸®¾Æ
      • ½ºÆäÀÎ
      • ±âŸ À¯·´ Áö¿ª
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÁÖ¿ä µ¿Çâ°ú ±âȸ
    • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : À¯Çüº°
      • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀÏȸ¿ë È£Èí¿ë ¸¶½ºÅ© ½ÃÀå : ½Ã¸®Á
    • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : ¿¬·ÉÃþº°
    • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : ÃÖÁ¾ »ç¿ëÀÚº°
    • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : ±¹°¡º°
      • ÀϺ»
      • Áß±¹
      • Àεµ
      • Çѱ¹
      • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • LAMEA
    • ÁÖ¿ä µ¿Çâ°ú ±âȸ
    • LAMEAÀÇ ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : À¯Çüº°
      • LAMEAÀÇ ÀÏȸ¿ë È£Èí¿ë ¸¶½ºÅ© ½ÃÀå : ½Ã¸®Á
    • LAMEAÀÇ ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : ¿¬·ÉÃþº°
    • LAMEAÀÇ ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : ¿£µåÀ¯Àúº°
    • LAMEAÀÇ ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : ±¹°¡º°
      • ºê¶óÁú
      • »ç¿ìµð¾Æ¶óºñ¾Æ
      • ³²¾ÆÇÁ¸®Ä« °øÈ­±¹
      • ±âŸ LAMEA

Á¦8Àå ±â¾÷ Á¤¼¼

  • ¼Ò°³
  • ÁÖ¿ä ¼º°ø Àü·«
  • ÁÖ¿ä 10°³»çÀÇ Á¦Ç° ¸ÅÇÎ
  • °æÀï ´ë½Ãº¸µå
  • °æÇÕÀÇ È÷Æ® ¸Ê
  • ÁÖ¿ä ¹ßÀü

Á¦9Àå ±â¾÷ ÇÁ·ÎÇÊ

  • 3M
  • Honeywell International Inc,
  • Medline Industries, Inc
  • Zelinsky Group Ltd
  • ANSELL LTD
  • owens and minor
  • Cardinal Health
  • KOKEN LTD
  • Moldex Metric
  • RSG Safety
ksm 23.03.27

The global respiratory masks market was valued at $527.1 million in 2021, and is projected to reach $2,394.3 million by 2031, registering a CAGR of 16.4% from 2022 to 2031. A respiratory mask is a piece of equipment made to prevent the user from breathing potentially harmful atmospheres, such as dust, vapor, gas, and particle matter. A mask is defined as a  device which is worn over the mouth and nose to protect the respiratory system by filtering out dangerous substances (such as dusts, fumes, or bacteria) from inhaled air. Particulate respirator masks can only filter out particles; they are ineffective against gases or vapors. Such a respirator may be given a numerical rating, like 95 or 99 to represent the amounts of airborne particles filtered. In addition, a letter may be used to designate if something is relatively resistant (R), not resistant (NR), or substantially resistant (P) to the effects of oil on proper respirator operation.

The respiratory mask market is driven by rise in prevalence of COVID-19 and increase in the prevalence of respiratory disorders, such as asthma, chronic obstructive pulmonary disease (COPD), asthma, lung cancer, and obstructive sleep apnea (OSA). For instance, according to the World Health Organization (WHO), in September 2022, confirmed cases of COVID-19 are 600,555,262 including 6,472,914 deaths. Coronavirus disease (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus. Most people infected with the virus experience mild to moderate respiratory illness. As COVID-19 is spread through air, there is rise in demand for respiratory mask for prevention purpose. Hence, rise in the prevalence of COVID-19 disease is anticipated to fuel the growth of the respiratory mask market. Moreover,  adverse climate conditions and air pollution are the major causes that increase the prevalence rate of respiratory diseases, such as chronic obstructive pulmonary disease (COPD), asthma, lung cancer, and obstructive sleep apnea (OSA), which, in turn, boost the demand for respiratory masks, thereby augmenting the market growth. For instance, according to the World Cancer Research Fund International, in 2020, around 2,206,771 new lung cancer cases were diagnosed globally. Among them, 1,435,943 male and 770,828 female population got affected. Moreover, rising air pollution in environment and rise in the awareness among the people regarding the effectiveness of respiratory masks are anticipated to fuel the market growth.

In addition, governments globally have increased the expenditure on the healthcare sector. For instance, according to the Centers for Medicare & Medicaid Services, the U.S. healthcare spending grew by 9.7% from 2019 to 2020, reaching $4.1 trillion ($12,530 per person). Similarly, as per the Office for National Statistics, total healthcare expenditure in UK accounted for 12.8% of the gross domestic product (GDP) in 2020, as compared to 10.2% in 2019. Furthermore, it has been estimated that approximately 30% of the healthcare expenditure is used in upgrading the healthcare infrastructure, especially medical equipment and material used at public health centers, such as hospitals. Hence, rise in healthcare expenditure across the globe is expected to fuel the demand for respiratory mask application for prevention purpose, thereby boosting the market growth.

On the other hand, fluctuation in prices of protective face masks and production of non-biodegradable masks are some factors that are anticipated to restrain the growth of the respiratory mask market.

The respiratory mask market is segmented on the basis of type, age group, end user, and region. On the basis of type, market is segmented into disposable and reusable. The disposable mask segment is sub-categorized into N series, P series, and R series. On the basis of age group, the market is divided into neonatal and pediatric, adults, and geriatric. On the basis of end user, the market is divided into hospitals, nursing homes and clinics, trauma centers, and homecare. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Some of the major companies that operate in the global respiratory mask market include, 3M, AlphaProTech, ANSELL LTD, Cardinal Health, Delta Plus Group, Honeywell International Inc., KOKEN LTD., Macopharma., McKesson Corporation, Medline Industries, Inc., Moldex-Metric, Owens & Minor, RSG Safety, and Zelinsky Group Ltd.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the respiratory masks market analysis from 2021 to 2031 to identify the prevailing respiratory masks market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the respiratory masks market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global respiratory masks market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By End User

  • Hospitals, Nursing Homes and Clinics
  • Trauma Centers
  • Homecare

By Type

  • Reusable
  • Disposable
    • Series
    • N Series
    • P series
    • R Series

By Age Group

  • Neonatal and Pediatric
  • Adult 
  • Geriatric

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest Of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • South Korea
    • Rest Of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest Of LAMEA
  • Key Market Players
    • 3M
    • Honeywell International Inc,
    • Medline Industries, Inc
    • Zelinsky Group Ltd
    • ANSELL LTD
    • owens and minor
    • Cardinal Health
    • KOKEN LTD
    • Moldex Metric
    • RSG Safety

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market
  • 3.7.Patent Landscape

CHAPTER 4: RESPIRATORY MASKS MARKET, BY TYPE

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Disposable
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market analysis by country
    • 4.2.4 Disposable Respiratory Masks Market by Series
      • 4.2.4.1 N Series Market size and forecast, by region
      • 4.2.4.2 P series Market size and forecast, by region
      • 4.2.4.3 R Series Market size and forecast, by region
  • 4.3 Reusable
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market analysis by country

CHAPTER 5: RESPIRATORY MASKS MARKET, BY AGE GROUP

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Neonatal and Pediatric
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market analysis by country
  • 5.3 Adult 
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market analysis by country
  • 5.4 Geriatric
    • 5.4.1 Key market trends, growth factors and opportunities
    • 5.4.2 Market size and forecast, by region
    • 5.4.3 Market analysis by country

CHAPTER 6: RESPIRATORY MASKS MARKET, BY END USER

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 Hospitals, Nursing Homes and Clinics
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market analysis by country
  • 6.3 Trauma Centers
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market analysis by country
  • 6.4 Homecare
    • 6.4.1 Key market trends, growth factors and opportunities
    • 6.4.2 Market size and forecast, by region
    • 6.4.3 Market analysis by country

CHAPTER 7: RESPIRATORY MASKS MARKET, BY REGION

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 North America
    • 7.2.1 Key trends and opportunities
    • 7.2.2 North America Market size and forecast, by Type
      • 7.2.2.1 North America Disposable Respiratory Masks Market by Series
    • 7.2.3 North America Market size and forecast, by Age Group
    • 7.2.4 North America Market size and forecast, by End User
    • 7.2.5 North America Market size and forecast, by country
      • 7.2.5.1 U.S.
      • 7.2.5.1.1 Market size and forecast, by Type
      • 7.2.5.1.2 Market size and forecast, by Age Group
      • 7.2.5.1.3 Market size and forecast, by End User
      • 7.2.5.2 Canada
      • 7.2.5.2.1 Market size and forecast, by Type
      • 7.2.5.2.2 Market size and forecast, by Age Group
      • 7.2.5.2.3 Market size and forecast, by End User
      • 7.2.5.3 Mexico
      • 7.2.5.3.1 Market size and forecast, by Type
      • 7.2.5.3.2 Market size and forecast, by Age Group
      • 7.2.5.3.3 Market size and forecast, by End User
  • 7.3 Europe
    • 7.3.1 Key trends and opportunities
    • 7.3.2 Europe Market size and forecast, by Type
      • 7.3.2.1 Europe Disposable Respiratory Masks Market by Series
    • 7.3.3 Europe Market size and forecast, by Age Group
    • 7.3.4 Europe Market size and forecast, by End User
    • 7.3.5 Europe Market size and forecast, by country
      • 7.3.5.1 Germany
      • 7.3.5.1.1 Market size and forecast, by Type
      • 7.3.5.1.2 Market size and forecast, by Age Group
      • 7.3.5.1.3 Market size and forecast, by End User
      • 7.3.5.2 France
      • 7.3.5.2.1 Market size and forecast, by Type
      • 7.3.5.2.2 Market size and forecast, by Age Group
      • 7.3.5.2.3 Market size and forecast, by End User
      • 7.3.5.3 UK
      • 7.3.5.3.1 Market size and forecast, by Type
      • 7.3.5.3.2 Market size and forecast, by Age Group
      • 7.3.5.3.3 Market size and forecast, by End User
      • 7.3.5.4 Italy
      • 7.3.5.4.1 Market size and forecast, by Type
      • 7.3.5.4.2 Market size and forecast, by Age Group
      • 7.3.5.4.3 Market size and forecast, by End User
      • 7.3.5.5 Spain
      • 7.3.5.5.1 Market size and forecast, by Type
      • 7.3.5.5.2 Market size and forecast, by Age Group
      • 7.3.5.5.3 Market size and forecast, by End User
      • 7.3.5.6 Rest of Europe
      • 7.3.5.6.1 Market size and forecast, by Type
      • 7.3.5.6.2 Market size and forecast, by Age Group
      • 7.3.5.6.3 Market size and forecast, by End User
  • 7.4 Asia-Pacific
    • 7.4.1 Key trends and opportunities
    • 7.4.2 Asia-Pacific Market size and forecast, by Type
      • 7.4.2.1 Asia-Pacific Disposable Respiratory Masks Market by Series
    • 7.4.3 Asia-Pacific Market size and forecast, by Age Group
    • 7.4.4 Asia-Pacific Market size and forecast, by End User
    • 7.4.5 Asia-Pacific Market size and forecast, by country
      • 7.4.5.1 Japan
      • 7.4.5.1.1 Market size and forecast, by Type
      • 7.4.5.1.2 Market size and forecast, by Age Group
      • 7.4.5.1.3 Market size and forecast, by End User
      • 7.4.5.2 China
      • 7.4.5.2.1 Market size and forecast, by Type
      • 7.4.5.2.2 Market size and forecast, by Age Group
      • 7.4.5.2.3 Market size and forecast, by End User
      • 7.4.5.3 India
      • 7.4.5.3.1 Market size and forecast, by Type
      • 7.4.5.3.2 Market size and forecast, by Age Group
      • 7.4.5.3.3 Market size and forecast, by End User
      • 7.4.5.4 South Korea
      • 7.4.5.4.1 Market size and forecast, by Type
      • 7.4.5.4.2 Market size and forecast, by Age Group
      • 7.4.5.4.3 Market size and forecast, by End User
      • 7.4.5.5 Rest of Asia-Pacific
      • 7.4.5.5.1 Market size and forecast, by Type
      • 7.4.5.5.2 Market size and forecast, by Age Group
      • 7.4.5.5.3 Market size and forecast, by End User
  • 7.5 LAMEA
    • 7.5.1 Key trends and opportunities
    • 7.5.2 LAMEA Market size and forecast, by Type
      • 7.5.2.1 LAMEA Disposable Respiratory Masks Market by Series
    • 7.5.3 LAMEA Market size and forecast, by Age Group
    • 7.5.4 LAMEA Market size and forecast, by End User
    • 7.5.5 LAMEA Market size and forecast, by country
      • 7.5.5.1 Brazil
      • 7.5.5.1.1 Market size and forecast, by Type
      • 7.5.5.1.2 Market size and forecast, by Age Group
      • 7.5.5.1.3 Market size and forecast, by End User
      • 7.5.5.2 Saudi Arabia
      • 7.5.5.2.1 Market size and forecast, by Type
      • 7.5.5.2.2 Market size and forecast, by Age Group
      • 7.5.5.2.3 Market size and forecast, by End User
      • 7.5.5.3 South Africa
      • 7.5.5.3.1 Market size and forecast, by Type
      • 7.5.5.3.2 Market size and forecast, by Age Group
      • 7.5.5.3.3 Market size and forecast, by End User
      • 7.5.5.4 Rest of LAMEA
      • 7.5.5.4.1 Market size and forecast, by Type
      • 7.5.5.4.2 Market size and forecast, by Age Group
      • 7.5.5.4.3 Market size and forecast, by End User

CHAPTER 8: COMPANY LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Key developments

CHAPTER 9: COMPANY PROFILES

  • 9.1 3M
    • 9.1.1 Company overview
    • 9.1.2 Company snapshot
    • 9.1.3 Operating business segments
    • 9.1.4 Product portfolio
    • 9.1.5 Business performance
    • 9.1.6 Key strategic moves and developments
  • 9.2 Honeywell International Inc,
    • 9.2.1 Company overview
    • 9.2.2 Company snapshot
    • 9.2.3 Operating business segments
    • 9.2.4 Product portfolio
    • 9.2.5 Business performance
    • 9.2.6 Key strategic moves and developments
  • 9.3 Medline Industries, Inc
    • 9.3.1 Company overview
    • 9.3.2 Company snapshot
    • 9.3.3 Operating business segments
    • 9.3.4 Product portfolio
    • 9.3.5 Business performance
    • 9.3.6 Key strategic moves and developments
  • 9.4 Zelinsky Group Ltd
    • 9.4.1 Company overview
    • 9.4.2 Company snapshot
    • 9.4.3 Operating business segments
    • 9.4.4 Product portfolio
    • 9.4.5 Business performance
    • 9.4.6 Key strategic moves and developments
  • 9.5 ANSELL LTD
    • 9.5.1 Company overview
    • 9.5.2 Company snapshot
    • 9.5.3 Operating business segments
    • 9.5.4 Product portfolio
    • 9.5.5 Business performance
    • 9.5.6 Key strategic moves and developments
  • 9.6 owens and minor
    • 9.6.1 Company overview
    • 9.6.2 Company snapshot
    • 9.6.3 Operating business segments
    • 9.6.4 Product portfolio
    • 9.6.5 Business performance
    • 9.6.6 Key strategic moves and developments
  • 9.7 Cardinal Health
    • 9.7.1 Company overview
    • 9.7.2 Company snapshot
    • 9.7.3 Operating business segments
    • 9.7.4 Product portfolio
    • 9.7.5 Business performance
    • 9.7.6 Key strategic moves and developments
  • 9.8 KOKEN LTD
    • 9.8.1 Company overview
    • 9.8.2 Company snapshot
    • 9.8.3 Operating business segments
    • 9.8.4 Product portfolio
    • 9.8.5 Business performance
    • 9.8.6 Key strategic moves and developments
  • 9.9 Moldex Metric
    • 9.9.1 Company overview
    • 9.9.2 Company snapshot
    • 9.9.3 Operating business segments
    • 9.9.4 Product portfolio
    • 9.9.5 Business performance
    • 9.9.6 Key strategic moves and developments
  • 9.10 RSG Safety
    • 9.10.1 Company overview
    • 9.10.2 Company snapshot
    • 9.10.3 Operating business segments
    • 9.10.4 Product portfolio
    • 9.10.5 Business performance
    • 9.10.6 Key strategic moves and developments
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦